Neuronetics (STIM) launches the first National TMS Therapy Awareness Day. The event will take place each year on May 14 during May’s Mental Health Awareness Month. This day is dedicated to raising awareness of transcranial magnetic stimulation as a proven, non-drug treatment option for individuals living with major depressive disorder, depression with anxiety, and OCD, especially those who have not found relief through antidepressants.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STIM:
- Neuronetics’ Strong Revenue Performance and Strategic Initiatives Justify Buy Rating Despite Cash Burn Concerns
- Neuronetics Reports Strong Q1 2025 Growth
- Neuronetics Reports Strong Q1 Growth Amid Challenges
- Neuronetics CFO Steve Furlong to retire
- Neuronetics sees Q2 revenue $36M-$38M, consensus $36.69M